Opioid receptor: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 9: | Line 9: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | |||
*δ-opioid receptor | |||
[[4ej4]] – mOpR + naltrindole - mouse <br /> | **[[4ej4]] – mOpR + naltrindole - mouse <br /> | ||
*κ-opioid receptor | |||
[[4djh]] – hOpR + opioid antagonist - human <br /> | **[[4djh]] – hOpR + opioid antagonist - human <br /> | ||
*Nociceptin/orphanin FQ opioid receptor | |||
[[4ea3]] – hOpR + peptide mimetic <br /> | **[[4ea3]] – hOpR + peptide mimetic <br /> | ||
*μ-opioid receptor | |||
[[4dkl]] – mOpR + opioid antagonist <br /> | **[[4dkl]] – mOpR + opioid antagonist <br /> | ||
}} | |||
[[Category:Topic Page]] | [[Category:Topic Page]] |